|
|
|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
64,584,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Co.'s D-Domain powered autologous and allogeneic Chimeric Antigen Receptor T cells (CAR-Ts), including classical single infusion CAR-Ts product candidate, CART-ddBCMA, is for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM), defined as patients with either minimal response or disease progression within 60 days of last treatment. Co. is also developing its ARC-SparX programs, ACLX-001 in r/r MM and ACLX-002 and ACLX-003 in r/r acute myeloid leukemia and myelodysplastic syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
25,790 |
74,246 |
143,936 |
1,231,239 |
| Total Sell Value |
$1,764,096 |
$5,764,212 |
$10,145,714 |
$87,727,988 |
| Total People Sold |
2 |
3 |
5 |
7 |
| Total Sell Transactions |
5 |
13 |
22 |
84 |
| End Date |
2025-11-09 |
2025-08-08 |
2025-02-07 |
2024-02-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Lubner David Charles |
|
|
2026-01-20 |
4 |
AS |
$75.00 |
$450,000 |
D/D |
(6,000) |
21,659 |
|
- |
|
Lubner David Charles |
|
|
2026-01-20 |
4 |
OE |
$6.28 |
$37,680 |
D/D |
6,000 |
27,659 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2026-01-14 |
4 |
S |
$68.51 |
$402,997 |
D/D |
(5,882) |
23,749 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2026-01-13 |
4 |
S |
$65.51 |
$487,213 |
D/D |
(7,437) |
29,631 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2026-01-12 |
4 |
S |
$64.15 |
$393,286 |
D/D |
(6,131) |
37,068 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2026-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,064 |
43,199 |
|
- |
|
Elghandour Rami |
SEE REMARKS |
|
2026-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,991 |
782,467 |
|
- |
|
Gilson Michelle |
CHIEF FINANCIAL OFFICER |
|
2026-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,530 |
64,832 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2026-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,520 |
30,135 |
|
- |
|
Elghandour Rami |
SEE REMARKS |
|
2026-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
53,098 |
726,476 |
|
- |
|
Gilson Michelle |
CHIEF FINANCIAL OFFICER |
|
2026-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,340 |
44,302 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2026-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,021 |
13,615 |
|
- |
|
Elghandour Rami |
SEE REMARKS |
|
2026-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,459 |
673,378 |
|
- |
|
Gilson Michelle |
CHIEF FINANCIAL OFFICER |
|
2026-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,496 |
28,962 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2025-11-17 |
4 |
AS |
$90.00 |
$30,600 |
D/D |
(340) |
284 |
|
- |
|
Gilson Michelle |
CHIEF FINANCIAL OFFICER |
|
2025-10-15 |
4 |
AS |
$91.04 |
$488,315 |
D/D |
(5,364) |
8,466 |
|
- |
|
Gilson Michelle |
CHIEF FINANCIAL OFFICER |
|
2025-10-06 |
4 |
AS |
$86.22 |
$91,733 |
D/D |
(1,064) |
13,830 |
|
- |
|
Gilson Michelle |
CHIEF FINANCIAL OFFICER |
|
2025-10-03 |
4 |
AS |
$86.00 |
$419,870 |
D/D |
(4,882) |
14,894 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2025-09-30 |
4 |
AS |
$80.55 |
$1,709,723 |
D/D |
(21,034) |
624 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2025-09-29 |
4 |
AS |
$80.16 |
$5,852 |
D/D |
(73) |
21,658 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2025-09-26 |
4 |
AS |
$80.12 |
$993,155 |
D/D |
(12,396) |
21,731 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2025-09-19 |
4 |
AS |
$80.00 |
$24,000 |
D/D |
(300) |
34,127 |
|
- |
|
Heery Christopher |
CHIEF MEDICAL OFFICER |
|
2025-09-18 |
4 |
AS |
$80.01 |
$267,468 |
D/D |
(3,343) |
34,427 |
|
- |
|
Elghandour Rami |
SEE REMARKS |
|
2025-08-28 |
4 |
D |
$70.25 |
$38,422,395 |
D/D |
(546,938) |
617,919 |
|
- |
|
Behbahani Ali |
|
|
2025-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,621 |
2,706 |
|
- |
|
228 Records found
|
|
Page 1 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|